Chromosomal abnormalities are a leading cause of recurrent miscarriage, responsible for up to 50% of first-trimester losses, with autosomal trisomies accounting for around 60% of these cases.
Products of conception analysis after recurrent pregnancy loss provides rapid, actionable insights, helping clinicians guide families with informed counselling and future reproductive planning.
The Yourgene® QST*R Pregnancy Loss assay is designed for the in vitro quantitative detection of the six most common autosomal trisomies associated with pregnancy loss.
Using Quantitative Fluorescent Polymerase Chain Reaction (QF-PCR) technology, this assay is designed to amplify highly polymorphic short tandem repeat (STR) regions on the chromosomes of interest.
Yourgene QST*R Pregnancy Loss assay detects:
Additional markers for the X and Y chromosomes and the TAF9L marker allow assessment of the fetal sex chromosome abnormalities, supporting comprehensive aneuploidy analysis.
The Yourgene® QST*R Pregnancy Loss assay is compatible with most commonly employed DNA extraction protocols, thermal cyclers and capillary electrophoresis instruments.
This flexibility in approach is complemented by simple and easy to use analysis software for reporting. Results can be analysed through either Life Technologies GeneMapper™ or SoftGenetics GeneMarker® software.
GeneMarker’s® operation now includes a customised Trisomy Analysis function. By selecting BPG (Best Practice Guidelines) settings within the Trisomy Analysis function users can quickly and accurately measure allele ratios to obtain a full patient sample report within minutes.
If you have a question or would like to learn more about our products and services, we're here to help.